E-LIB Suche - Ergebnisse für: Kärppä, Mikko

1

Challenges and needs in cerebrovascular disease pathway: A ..:

Härkönen, Henna ; Myllykangas, Kirsi ; Gomes, Julius...
Journal of Advanced Nursing. , 2024

2

Patient experiences on the quality of cerebrovascular disea..:

Myllykangas, Kirsi ; Härkönen, Henna ; Kääriäinen, Maria..
Journal of Clinical Nursing. 33 (2024) 6 - p. 2259-2273 , 2024

Link: https://doi.org/10.1111/..

3

Status epilepticus in POLG disease: a large multinational s..:

Hikmat, Omar ; Naess, Karin ; Engvall, Martin...
Journal of Neurology. , 2024

Link: https://doi.org/10.1007/..

4

Feasibility and patient acceptability of a commercially ava..:

Liikkanen, Sammeli ; Sinkkonen, Janne ; Suorsa, Joni...
PLOS Digital Health. 2 (2023) 4 - p. e0000225 , 2023

Link: https://doi.org/10.1371/..

5

Impact of age and sex on the efficacy of fremanezumab in pa..:

MaassenVanDenBrink, Antoinette ; Terwindt, Gisela M. ; Cohen, Joshua M....
The Journal of Headache and Pain. 22 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

6

Efficacy and safety of fremanezumab in patients with migrai..:

Spierings, Egilius L. H. ; Kärppä, Mikko ; Ning, Xiaoping...
The Journal of Headache and Pain. 22 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

7

Long-term effectiveness and safety of lemborexant in adults..:

Yardley, Jane ; Kärppä, Mikko ; Inoue, Yuichi...
Sleep Medicine. 80 (2021) - p. 333-342 , 2021

Link: https://doi.org/10.1016/..

8

165 Impact of Lemborexant on Insomnia Disease Severity and ..:

Moline, Margaret ; Kärppä, Mikko ; Yardley, Jane...
CNS Spectrums. 25 (2020) 2 - p. 305-306 , 2020

Link: https://doi.org/10.1017/..

9

Efficacy and Safety of Lemborexant in Elderly Subjects with..:

Moline, Margaret ; Yardley, Jane ; Pinner, Kate...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

10

Impact of Lemborexant Treatment on Insomnia Disease Severit..:

Moline, Margaret ; Kärppä, Mikko ; Yardley, Jane...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

11

Long-term efficacy and tolerability of lemborexant compared..:

Kärppä, Mikko ; Yardley, Jane ; Pinner, Kate...
Sleep. 43 (2020) 9 - p. , 2020

Link: https://doi.org/10.1093/..

12

Effectiveness and Safety of Lemborexant Over 12 Months in A..:

Yardley, Jane ; Kärppä, Mikko ; Inoue, Yuichi...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

13

Efficacy of Fremanezumab in Male Patients With Migraine and..:

MaassenVanDenBrink, Antoinette ; Terwindt, Gisela ; Cohen, Joshua...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

14

Screening for Fabry disease and hereditary ATTR amyloidosis..:

Hietaharju, Aki J. ; Samuelsson, Kristin ; Radovic, Ana...
Molecular Genetics and Metabolism. 126 (2019) 2 - p. S72-S73 , 2019

Link: https://doi.org/10.1016/..

15

0367 Lemborexant Treatment for Insomnia: 6-month Safety:

Kärppä, Mikko ; Moline, Margaret ; Yardley, Jane...
Sleep. 42 (2019) Supplement_1 - p. A149-A150 , 2019

Link: https://doi.org/10.1093/..